Rare diseases collectively affect millions globally yet present unique diagnostic challenges due to their low prevalence and clinical heterogeneity. Genomic technologies have revolutionised rare ...
PM ETSAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The Bionano business is healthy, ...
International momentum is evidenced by the 2026 symposium attracting participants from 73 countries, and highlighting OGM ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The Bionano business is healthy, with first ...
A major goal of modern crop breeding is to efficiently combine multiple desirable traits by "stacking" the favorable gene ...
Earnings call Bionano Genomics delivered Q1 2026 revenue of $6.7M, up 4% YoY and at the high end of guidance, with consumable revenue up 20% and flow cell unit sales up 17%. Adjusted gross margin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results